156 related articles for article (PubMed ID: 19039196)
1. t(11;18)(q21;q21)-positive advanced-stage MALT lymphoma associated with monoclonal gammopathy: resistance to rituximab or rituximab-containing chemotherapy.
Ohno H; Isoda K
J Clin Exp Hematop; 2008 Nov; 48(2):47-54. PubMed ID: 19039196
[TBL] [Abstract][Full Text] [Related]
2. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
[TBL] [Abstract][Full Text] [Related]
3. t(14;18)(q32;q21)-bearing pleural MALT lymphoma with IgM paraproteinemia: value of detection of specific cytogenetic abnormalities in the differential diagnosis of MALT lymphoma and lymphoplasmacytic lymphoma.
Gomyo H; Kajimoto K; Maeda A; Mizuno I; Funada Y; Koizumi T; Fukui E; Hanioka K; Ogura M; Murayama T
Hematology; 2007 Aug; 12(4):315-8. PubMed ID: 17654058
[TBL] [Abstract][Full Text] [Related]
4. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.
Raderer M; Jäger G; Brugger S; Püspök A; Fiebiger W; Drach J; Wotherspoon A; Chott A
Oncology; 2003; 65(4):306-10. PubMed ID: 14707449
[TBL] [Abstract][Full Text] [Related]
5. Mucosa-associated lymphoid tissue (MALT) lymphoma of the rectum with chromosomal translocation of the t(11;18)(q21;q21) and an additional aberration of trisomy 3.
Hosaka S; Akamatsu T; Nakamura S; Kaneko T; Kitano K; Kiyosawa K; Ota H; Hosaka N; Miyabayashi H; Katsuyama T
Am J Gastroenterol; 1999 Jul; 94(7):1951-4. PubMed ID: 10406266
[TBL] [Abstract][Full Text] [Related]
6. t (11;18)(q21;q21) chromosome translocation (A1446-M1150) of MALT lymphoma in buccal mucosa.
Tanaka T; Iino M
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1783-5. PubMed ID: 20676680
[TBL] [Abstract][Full Text] [Related]
7. Chronic autoimmune thyroiditis (Hashimoto's thyroiditis) in patients with MALT lymphoma.
Troch M; Woehrer S; Streubel B; Weissel M; Hoffmann M; Müllauer L; Chott A; Raderer M
Ann Oncol; 2008 Jul; 19(7):1336-1339. PubMed ID: 18334510
[TBL] [Abstract][Full Text] [Related]
8. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.
Liu H; Ye H; Ruskone-Fourmestraux A; De Jong D; Pileri S; Thiede C; Lavergne A; Boot H; Caletti G; Wündisch T; Molina T; Taal BG; Elena S; Thomas T; Zinzani PL; Neubauer A; Stolte M; Hamoudi RA; Dogan A; Isaacson PG; Du MQ
Gastroenterology; 2002 May; 122(5):1286-94. PubMed ID: 11984515
[TBL] [Abstract][Full Text] [Related]
9. t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement.
Kuo SH; Cheng AL; Lin CW; Hsu CH; Wu MS; Yeh KH; Tzeng YS; Chen LT
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1387-95. PubMed ID: 21465313
[TBL] [Abstract][Full Text] [Related]
10. Mucosa-associated lymphoid tissue lymphoma with t(11;18)(q21;q21) translocation: long-term follow-up results.
Toyoda K; Maeshima AM; Nomoto J; Suzuki T; Yuda S; Yamauchi N; Taniguchi H; Makita S; Fukuhara S; Munakata W; Maruyama D; Tobinai K; Kobayashi Y
Ann Hematol; 2019 Jul; 98(7):1675-1687. PubMed ID: 30923996
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal gammopathy after low-grade MALT lymphoma: evidence for a second neoplasm.
Pachmann S; Anderegg B; Müller-Höcker J; Nathrath W; Brack N; Tigges FJ; Hartenstein R; Munker R
Am J Hematol; 2002 Jun; 70(2):167-73. PubMed ID: 12111792
[TBL] [Abstract][Full Text] [Related]
12. Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up.
Lévy M; Copie-Bergman C; Molinier-Frenkel V; Riou A; Haioun C; Gaulard P; Delfau-Larue MH; Sobhani I; Leroy K; Delchier JC
Leuk Lymphoma; 2010 Feb; 51(2):284-90. PubMed ID: 20038225
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type.
Nakamura T; Nakamura S; Yonezumi M; Suzuki T; Matsuura A; Yatabe Y; Yokoi T; Ohashi K; Seto M
Jpn J Cancer Res; 2000 Mar; 91(3):301-9. PubMed ID: 10760689
[TBL] [Abstract][Full Text] [Related]
14. Coexistence of mucosa-associated lymphoid tissue lymphoma with plasma cell features and adenocarcinoma cells in pleural fluid.
Ohno H
J Clin Exp Hematop; 2010; 50(1):75-7. PubMed ID: 20505280
[No Abstract] [Full Text] [Related]
15. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy.
Martinelli G; Laszlo D; Ferreri AJ; Pruneri G; Ponzoni M; Conconi A; Crosta C; Pedrinis E; Bertoni F; Calabrese L; Zucca E
J Clin Oncol; 2005 Mar; 23(9):1979-83. PubMed ID: 15668468
[TBL] [Abstract][Full Text] [Related]
16. Persistent residual disease in t(11;18)(q21;q21) positive gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy or rituximab.
Salar A; Bellosillo B; Serrano S; Besses C
J Clin Oncol; 2005 Oct; 23(29):7361-2; author reply 7362-3. PubMed ID: 16210674
[No Abstract] [Full Text] [Related]
17. Regression of pulmonary MALT lymphoma after treatment with rituximab.
Chong EA; Svoboda J; Cherian S; Andreadis C; Downs LH; Zhuang H; Alavi A; Tsai DE; Schuster SJ
Leuk Lymphoma; 2005 Sep; 46(9):1383-6. PubMed ID: 16109620
[TBL] [Abstract][Full Text] [Related]
18. Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone.
Aguiar-Bujanda D; Llorca-Mártinez I; Rivero-Vera JC; Blanco-Sánchez MJ; Jiménez-Gallego P; Mori-De Santiago M; Limeres-Gonzalez MA; Cabrera-Marrero JC; Hernández-Sosa M; Galván-Ruíz S; Hernández-Sarmiento S; Saura Grau S; Bohn-Sarmiento U
Hematol Oncol; 2014 Sep; 32(3):139-44. PubMed ID: 24123108
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal translocation t(11;18)(q21;q21) in gastrointestinal mucosa associated lymphoid tissue lymphoma.
Nakamura S; Matsumoto T; Nakamura S; Jo Y; Fujisawa K; Suekane H; Yao T; Tsuneyoshi M; Iida M
J Clin Pathol; 2003 Jan; 56(1):36-42. PubMed ID: 12499431
[TBL] [Abstract][Full Text] [Related]
20. Treatment of localized oral MALT lymphoma by rituximab: a case report.
Yamagata K; Onizawa K; Kojima H; Yoshida H
Oral Maxillofac Surg; 2008 Dec; 12(4):227-30. PubMed ID: 18830723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
